PatientsVille.com LogoTemsirolimus Side Effects

How can Temsirolimus Side Effects affect You? | PatientsVille.com

View and Submit Temsirolimus Side Effects

Your Temsirolimus Side Effect submission can play a very important role. Reporting your experience could help identify an unknown risk and inform other patients and health care professionals.

View and Report Temsirolimus Side Effects Click Check Boxes Below to Submit a Side Effect or Use a Link for Additional Health Information
Edema (1)
>>View All User Submitted Temsirolimus Side Effects

Temsirolimus Side Effects and Adverse Effects reported to US Food and Drug Administration (FDA)

Spread the word: Share, Email, Print

Showing 1-25 of 1065 

Non-hodgkin's Lymphoma, Disease Progression (8381338-2)
on May 11, 2012 Male from ROMANIA , 73 years of age, weighting 112.4 lb, was diagnosed with
  • mantle cell lymphoma
and was treated with Temsirolimus. Directly after, patient experienced the unwanted or unexpected Temsirolimus side effects: non-hodgkin's lymphoma, disease progression. Temsirolimus dosage: 50 Mg, Unk.
Associated medications used:
  • Desipramide Hcl (50 Mg, Weekly, For Two Weeks)


Pneumocystis Jiroveci Pneumonia (8377566-2)
Patient was taking Temsirolimus. Patient felt the following Temsirolimus side effects: pneumocystis jiroveci pneumonia on May 16, 2012 from JAPAN Additional patient health information: Male , 57 years of age, was diagnosed with
  • metastatic renal cell carcinoma
and. Temsirolimus dosage: 25 Mg, Cyclic, Weekly.

Anaemia, Cough, Decreased Appetite, Hyperlipidaemia, Leukopenia, Malaise (8377277-3)
Adverse event was reported on May 15, 2012 by a Female taking Temsirolimus (Dosage: N/A) was diagnosed with
  • metastatic renal cell carcinoma
and. Location: TAIWAN, PROVINCE OF CHINA , 40 years of age, After Temsirolimus was administered, patient encountered several Temsirolimus side effects: anaemia, cough, decreased appetite, hyperlipidaemia, leukopenia, malaise.

Pleural Effusion (8373706-X)
on May 14, 2012 Male from CZECH REPUBLIC , weighting 149.9 lb, was diagnosed with
  • metastatic renal cell carcinoma
and was treated with Temsirolimus. Directly after, patient experienced the unwanted or unexpected Temsirolimus side effects: pleural effusion. Temsirolimus dosage: N/A.
Associated medications used:
  • Avastin
Patient was hospitalized.


Lymphopenia (8373419-4)
on Nov 09, 2011 Female from UNITED STATES , 71 years of age, weighting 233.7 lb, was diagnosed with
  • b-cell lymphoma
and was treated with Temsirolimus. Patient felt the following Temsirolimus side effects: lymphopenia. Temsirolimus dosage: N/A.
Multiple prescriptions taken:
  • Acetaminophen
  • Lopedium
  • Dimetindene Maleate
  • Bendamustine Hydrochloride
  • Dimenhydrinate
  • Simvastatin
  • Allopurinol
  • Cefatrizine Propyleneglycol Sulfate


(8365447-X)
Patient was taking Temsirolimus. on May 11, 2012 from ROMANIA Additional patient health information: Male , 73 years of age, weighting 112.4 lb, was diagnosed with
  • mantle cell lymphoma
and. Temsirolimus dosage: 50 Mg, Unk.
Multiple concurrent drugs taken:
  • Desipramine Hcl (50 Mg, Weekly, For Two Weeks)


Hyperkalaemia (8364242-5)
Adverse event was reported on May 14, 2012 by a Male taking Temsirolimus (Dosage: 20 Mg, Unk) . Location: JAPAN , 77 years of age, weighting 105.8 lb, Directly after, patient experienced the unwanted or unexpected Temsirolimus side effects: hyperkalaemia. Patient was hospitalized.

Sinusitis (8359622-8)
on May 09, 2012 Male from POLAND , 57 years of age, was treated with Temsirolimus. Patient felt the following Temsirolimus side effects: sinusitis. Temsirolimus dosage: 75 Mg, After 175 Mg Dose, Then Once Weekly. Patient was hospitalized.

Neoplasm Malignant, Bile Duct Cancer (8356708-9)
on May 08, 2012 Female from JAPAN , 51 years of age, weighting 94.80 lb, was diagnosed with
  • metastatic renal cell carcinoma
  • prophylaxis
and was treated with Temsirolimus. After Temsirolimus was administered, patient encountered several Temsirolimus side effects: neoplasm malignant, bile duct cancer. Temsirolimus dosage: 25 Mg, Weekly.
Multiple concurrent drugs taken:
  • Restamin (50 Mg, 1x/day)


Fracture (8352403-0)
Patient was taking Temsirolimus. Directly after, patient experienced the unwanted or unexpected Temsirolimus side effects: fracture on May 08, 2012 from JAPAN Additional patient health information: Female , 78 years of age, weighting 132.3 lb, was diagnosed with
  • metastatic renal cell carcinoma
and. Temsirolimus dosage: 25 Mg, Weekly.
Associated medications used:
  • Amlodipine (5 Mg, 1x/day)
  • Allopurinol (300 Mg, 1x/day)
  • Adalat (20 Mg, 1x/day)
  • Candesartan Cilexetil And Hydrochlorothiazide
Patient was hospitalized.

Hypokalaemia, Hypophosphataemia (8337011-X)
Adverse event was reported on Apr 30, 2012 by a Female taking Temsirolimus (Dosage: 15 Mg, Weekly) was diagnosed with
  • breast cancer
and. Location: FRANCE , 57 years of age, weighting 160.9 lb, Patient felt the following Temsirolimus side effects: hypokalaemia, hypophosphataemia.
Multiple prescriptions taken:
  • Neratinib (240 Mg, 1x/day)
  • Lexomil (Unk)
  • Zometa (Unk)
  • Lyrica (Unk)
  • Paroxetine Hydrochloride (Unk)


Sinusitis (8333842-0)
on Apr 26, 2012 Male from POLAND , 57 years of age, was diagnosed with
  • mantle cell lymphoma
and was treated with Temsirolimus. After Temsirolimus was administered, patient encountered several Temsirolimus side effects: sinusitis. Temsirolimus dosage: 175 Mg, Once Weekly For The First 3 Weeks. Patient was hospitalized.

White Blood Cell Count Decreased, Bone Marrow Failure, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased (8333423-9)
on May 03, 2012 Female from JAPAN , child 10 years of age, weighting 52.47 lb, was treated with Temsirolimus. Directly after, patient experienced the unwanted or unexpected Temsirolimus side effects: white blood cell count decreased, bone marrow failure, aspartate aminotransferase increased, alanine aminotransferase increased. Temsirolimus dosage: 25 Mg, Weekly.
Associated medications used:
  • Micafungin Sodium
  • Neutrogin (100 Ug, 1x/day)
  • Topotecan (47 Mg, 1x/day)
  • Topotecan (47 Mg, 1x/day)
  • Meropenem (0.5 G, 3x/day)
  • Glycyrrhizin/glycine/l-cysteine Hydrochloride
  • Bactrim (Unk)
  • Loperamide Hcl
Patient was hospitalized.

Capillary Leak Syndrome, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Ascites, Alanine Aminotransferase Increased (8323099-9)
Patient was taking Temsirolimus. Patient felt the following Temsirolimus side effects: capillary leak syndrome, aspartate aminotransferase increased, blood creatinine increased, ascites, alanine aminotransferase increased on Apr 19, 2012 from SWITZERLAND Additional patient health information: Male , 39 years of age, was diagnosed with
  • non-hodgkin's lymphoma
and. Temsirolimus dosage: 15 Mg, Cyclic, Weekly.
Multiple prescriptions taken:
  • Inotuzumab Ozogamicin (1.6 Mg, Cyclic, Every 4 Weeks)
  • Crestor (5 Mg, Unk)
  • Crestor
Patient was hospitalized.

Pneumonia Bacterial, Interstitial Lung Disease (8320578-5)
Adverse event was reported on Apr 25, 2012 by a Male taking Temsirolimus (Dosage: 25 Mg, Unk) . Location: JAPAN , 68 years of age, weighting 79.37 lb, After Temsirolimus was administered, patient encountered several Temsirolimus side effects: pneumonia bacterial, interstitial lung disease. Patient was hospitalized.

Intestinal Ischaemia, Small Intestinal Obstruction (8320279-3)
on Apr 26, 2012 Male from UNITED STATES , 62 years of age, weighting 173.3 lb, was diagnosed with
  • diffuse large b-cell lymphoma
and was treated with Temsirolimus. Directly after, patient experienced the unwanted or unexpected Temsirolimus side effects: intestinal ischaemia, small intestinal obstruction. Temsirolimus dosage: 15mg,weekly, Iv.
Associated medications used:
  • Acyclovir
  • Oxycontin
  • Dilaudid
  • Emend
  • Zoloft
  • Velcade (1.6mg/m2,weekly, Iv)
Patient was hospitalized.

Pneumocystis Jiroveci Pneumonia (8317029-3)
on Apr 20, 2012 Male from FRANCE , 62 years of age, weighting 167.6 lb, was treated with Temsirolimus. Patient felt the following Temsirolimus side effects: pneumocystis jiroveci pneumonia. Temsirolimus dosage: 25 Mg, Cyclic.
Multiple prescriptions taken:
  • Doxorubicin Hcl (Unk)
  • Cyclophosphamide (Unk)
  • Vincristine Sulfate
  • Prednisone
  • Rituximab (Unk)
Patient was hospitalized.

Respiratory Failure (8313200-5)
Patient was taking Temsirolimus. After Temsirolimus was administered, patient encountered several Temsirolimus side effects: respiratory failure on Apr 20, 2012 from JAPAN Additional patient health information: Female , 48 years of age, weighting 80.03 lb, was diagnosed with
  • metastatic renal cell carcinoma
and. Temsirolimus dosage: 25 Mg, Unk.
Multiple concurrent drugs taken:
  • Decadron (6.6 Mg, 1x/day)
  • Famotidine (Unk Mg, Unk)
  • Magmitt (Unk)
  • Vena (Unk Mg, Unk)
  • Ferrous Citrate (50 Mg, 1x/day)
  • Lasix (Unk)


(8313124-3)
Adverse event was reported on Apr 20, 2012 by a Female taking Temsirolimus (Dosage: 15 Mg, Weekly) . Location: JAPAN , 59 years of age, weighting 92.59 lb, .
Associated medications used:
  • Magmitt (750 Mg, 3x/day)


Deep Vein Thrombosis, Shunt Infection, Sepsis, Pyrexia, Renal Cell Carcinoma, Sputum Retention, Respiratory Depression, Pneumonia Bacterial, Disease Progression (8313113-9)
on Apr 19, 2012 Male from JAPAN , 59 years of age, weighting 108.0 lb, was diagnosed with
  • renal cell carcinoma
and was treated with Temsirolimus. Patient felt the following Temsirolimus side effects: deep vein thrombosis, shunt infection, sepsis, pyrexia, renal cell carcinoma, sputum retention, respiratory depression, pneumonia bacterial, disease progression. Temsirolimus dosage: 25 Mg, Weekly. Patient was hospitalized.

Anaphylactic Shock, Interstitial Lung Disease (8313070-5)
on Apr 23, 2012 Female from JAPAN , 32 years of age, weighting 117.9 lb, was treated with Temsirolimus. After Temsirolimus was administered, patient encountered several Temsirolimus side effects: anaphylactic shock, interstitial lung disease. Temsirolimus dosage: 25 Mg, Weekly.

Pyrexia, Neuroendocrine Carcinoma Of The Skin, Chest Pain, Abdominal Pain, Dyspnoea (8310735-6)
Patient was taking Temsirolimus. Directly after, patient experienced the unwanted or unexpected Temsirolimus side effects: pyrexia, neuroendocrine carcinoma of the skin, chest pain, abdominal pain, dyspnoea on Apr 19, 2012 from UNITED STATES Additional patient health information: Male , weighting 190.5 lb, . Temsirolimus dosage: 25 Milligram.
Associated medications used:
  • Ativan (.25 Milligram)
  • Ms Contin (30 Milligram)
  • Senna (2 Tablet)
  • Flomax (.4 Milligram)
  • Haloperidol
  • Valacyclovir (1 Gram)
  • Cefepime
  • Thorazine (25 Milligram)
Patient was hospitalized.

Renal Cell Carcinoma, Disease Progression, Dyspnoea, Stomatitis, Hyperglycaemia, Lung Infiltration, Disorientation, Rash, Pyrexia (8309965-9)
Adverse event was reported on Apr 19, 2012 by a Female taking Temsirolimus (Dosage: 25 Mg, Weekly) was diagnosed with
  • renal cell carcinoma
and. Location: ARGENTINA , 51 years of age, Patient felt the following Temsirolimus side effects: renal cell carcinoma, disease progression, dyspnoea, stomatitis, hyperglycaemia, lung infiltration, disorientation, rash, pyrexia. Patient was hospitalized.

Liver Disorder, Disease Progression, Renal Cell Carcinoma (8308777-X)
on Apr 19, 2012 Female from JAPAN , 56 years of age, weighting 108.5 lb, was diagnosed with
  • renal cell carcinoma
  • prophylaxis
and was treated with Temsirolimus. After Temsirolimus was administered, patient encountered several Temsirolimus side effects: liver disorder, disease progression, renal cell carcinoma. Temsirolimus dosage: 25 Mg, Weekly.
Multiple concurrent drugs taken:
  • Vena (5 Df, 1x/day)
  • Lansoprazole (30 Mg (1 Tablet), 1x/day)
Patient was hospitalized.

Vena Cava Thrombosis (8307781-5)
on Apr 13, 2012 Female from FRANCE , 59 years of age, was diagnosed with
  • neoplasm
  • metastasis
and was treated with Temsirolimus. Directly after, patient experienced the unwanted or unexpected Temsirolimus side effects: vena cava thrombosis. Temsirolimus dosage: 15 Mg, Weekly.
Associated medications used:
  • Erbitux
  • Nexium (20 Mg, 1x/day)
  • Magne-b6 (2 Df, 3x/day)
Patient was hospitalized.

Showing 1-25 of 1065 

Temsirolimus Health Episodes

Discuss Temsirolimus Side Effects

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Temsirolimus Information

More About Temsirolimus

Side Effects reported to FDA: 1065. View Temsirolimus Adverse Reports

Temsirolimus safety alerts: No

Reported deaths: 238

Reported hospitalizations: 776

Managing Your Medicines

Tips for Taking Medicines Properly

Before Taking Temsirolimus

Find Out How to Take Temsirolimus

Did You Have a Temsirolimus Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Temsirolimus for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective